9AT: LYNX1 CAPITAL MANAGEMENT LP

other names

LYNX1 CAPITAL MANAGEMENT LP

Adviser Profile

As of Date	06/23/2025
Adviser Type - Large advisory firm
Number of Employees	5 67%
of those in investment advisory functions	1 -67%
Registration	SEC, Approved, 04/05/2023
Other registrations (5)	SEC, ERA - Withdrawn, 03/03/2023 Puerto Rico, ERA - Withdrawn, 03/03/2023 Puerto Rico, ERA - Active, 02/04/2022 SEC, ERA - Active, 10/13/2021 SEC, Terminated, 12/11/2020
Former registrations	LYNX1 CAPITAL MANAGEMENT LP LYNX1 CAPITAL MANAGEMENT LP

AUM^*	310,306,368 127%
of that, discretionary	310,306,368 127%
Private Fund GAV^*	279,790,068 17%
Avg Account Size	62,061,274 36%
SMA’s	No
Private Funds	5
Contact Info	703 xxxxxxx

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Fund Type	Count	GAV
Fund TypeHedge Fund	Count4	GAV$278,424,530
Fund TypePrivate Equity Fund	Count1	GAV$1,365,538

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser CATALYST WEALTH MANAGEMENT	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM71.7m	#Funds-
Adviser TANO CAPITAL, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund17.7m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV17.7m	AUM118.1m	#Funds1
Adviser KELLY PARK INVESTMENT LLC	Hedge Fund26.4m	Liquidity Fund-	Private Equity Fund1.8m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV28.2m	AUM186.2m	#Funds5
Adviser SM INVESTORS	Hedge Fund58.5m	Liquidity Fund-	Private Equity Fund12.9m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV71.3m	AUM82.8m	#Funds5
Adviser ALTAI CAPITAL MANAGEMENT, L.P.	Hedge Fund36.4m	Liquidity Fund-	Private Equity Fund258.0k	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV36.6m	AUM136.1m	#Funds2
Adviser MAQRO ADVISORS LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund80.0m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV80.0m	AUM184.9m	#Funds2
Adviser CROSS SHORE CAPITAL MANAGEMENT, LLC	Hedge Fund151.6m	Liquidity Fund-	Private Equity Fund26.7m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV178.3m	AUM134.5m	#Funds6
Adviser SEASON INVESTMENTS, LLC	Hedge Fund39.6m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV39.6m	AUM142.6m	#Funds1
Adviser TAH MANAGEMENT, LP	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM165.8m	#Funds-
Adviser GORDONMD GLOBAL INVESTMENTS LP	Hedge Fund150.8m	Liquidity Fund-	Private Equity Fund108.2m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV259.0m	AUM259.0m	#Funds9

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck TickerN5749R100	Stock NameMERUS N V	$ Position$144,439,375	% Position29.00%	$ Change75.00%	# Change-2.00%
Stck Ticker86150R107	Stock NameSTOKE THERAPEUTICS INC	$ Position$109,881,253	% Position22.00%	$ Change79.00%	# Change0.00%
Stck TickerG3855L106	Stock NameGH RESEARCH PLC	$ Position$104,311,679	% Position21.00%	$ Change27.00%	# Change27.00%
Stck Ticker74366E102	Stock NamePROTAGONIST THERAPEUTICS INC	$ Position$46,501,930	% Position9.00%	$ Change15.00%	# Change-5.00%
Stck Ticker230031106	Stock NameCULLINAN THERAPEUTICS INC	$ Position$34,192,914	% Position7.00%	$ Change3.00%	# Change31.00%
Stck Ticker12529R107	Stock NameC4 THERAPEUTICS INC	$ Position$15,757,855	% Position3.00%	$ Change55.00%	# Change0.00%
Stck Ticker89854M101	Stock NameTSCAN THERAPEUTICS INC	$ Position$14,300,372	% Position3.00%	$ Change26.00%	# Change0.00%
Stck Ticker24823R105	Stock NameDENALI THERAPEUTICS INC	$ Position$3,799,695	% Position1.00%	$ Change	# Change
Stck TickerH0036K147	Stock NameADC THERAPEUTICS SA	$ Position$5,303,392	% Position1.00%	$ Change	# Change
Stck Ticker702712209	Stock NamePASSAGE BIO INC	$ Position$5,008,343	% Position1.00%	$ Change	# Change

Brochure Summary

Overview

Lynx1 Capital Management LP (“LCM”) is a Delaware limited partnership that was formed in May 2020. Lynx1 Capital Advisors LLC (“LCA”), its relying adviser, is a Puerto Rico limited liability company that was formed in August 2020. LCM and LCA are jointly referred to herein as the “Firm.” The Firm is principally owned and controlled by Weston Nichols, the Firm’s Chief Investment Officer (the “CIO”). LCM provides discretionary investment advice to the following private funds (together, the “Flagship Funds”): (i) Lynx1 Onshore Fund LP (the “Onshore Fund”) and (ii) Lynx1 Master Fund LP (the “Master Fund”). The Onshore Fund is a feeder fund that invests through the Master Fund. The Firm also provides discretionary investment advice to Lynx1 Opportunity Fund I LP (the “Opportunity Fund” and collectively with the Flagship Funds, the “Funds”). The Firm also sub-advises a fund through a separately managed account (the “SMA”). LCA serves as the sub-adviser to the Funds. The Firm may also provide investment advice to additional private funds and expects to provide investment advice to SMAs primarily for institutional, non-retail investors. References

throughout this document to “clients” refer to the Funds and any other private funds and SMAs that the Firm may advise in the future. Client accounts are managed in accordance with their own investment and trading objectives, as described in their respective offering documents, governing agreements or advisory agreements (collectively, the “Governing Documents”), as applicable. The Firm does not permit investors in the Funds to impose limitations on the investment activities described in the Funds’ Governing Documents. Under certain circumstances, the Firm may contract with a client to adhere to limited risk and/or operating guidelines imposed by that client. The Firm would negotiate such arrangements on a case-by-case basis. (See Item 16 - Investment Discretion.) Lynx1 Fund GP LLC, one of the Firm’s related persons (the “Lynx1 GP”), serves as the general partner to certain Funds. The Firm does not participate in wrap fee programs. As of December 31, 2023, the Firm managed $268,343,489 of regulatory assets under management on a discretionary basis. The Firm does not manage any assets on a non-discretionary basis.

Revenue	{{ Info.Revenue \| formatUSD }}
Headquarters	{{ Info.Headquarters }}

LYNX1 CAPITAL MANAGEMENT LP

Related Companies

Adviser Profile

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview